FemTech Market Size, Share, and Trends Analysis, By Component (Hardware, Consumables, Software, Services), By Technology (DNA-Based, RNA-Based, Others), By Application (Data Storage & Archival, Computation & Optimization, Others), By End-Use, and By Region, Forecast 2026-2033

FemTech Market Overview and Key Insights:

The global FemTech market reached USD 31.53 billion in 2025 and is expected to register a revenue CAGR of 17.2% during the forecast period. Growing awareness and focus on women’s health, rising prevalence of women-specific health conditions, increasing adoption of telehealth and virtual care models and rising investment and funding in FemTech startups are expected to drive revenue growth of the market.

Market Drivers:

Growing awareness and focus on women’s health are driving strong revenue growth of the market. Women’s health is increasingly receiving global focus, supported by improved education, growing digital literacy, and shifting social perspectives. Rising awareness of gender-specific concerns, including menstrual health, fertility, menopause, and mental well-being is motivating women to embrace preventive, data-oriented healthcare approaches. Widespread access to smartphones and wearable technologies has further strengthened this shift by supporting real-time monitoring and personalized health management.

Public institutions and governments are contributing significantly to this momentum. In May 2025, the University of Miami Miller School of Medicine introduced a FemTech Program aimed at advancing technology-driven solutions for women’s healthcare through interdisciplinary collaboration. Similarly, in March 2024, the National Health Service announced dedicated funding for women-focused digital health innovations, with particular emphasis on menstrual and menopause care. Entrepreneurial activity is also accelerating market revenue growth. Arva Health raised USD 1 million in May 2025 to expand affordable fertility clinics across India, while Maven Clinic secured USD 90 million in November 2022 to scale its women-centric teletherapy services. 

Market Opportunity:

Rising focus on menopause and healthy aging is creating significant opportunities for the market. Women are increasingly seeking personalised, preventive, and long-term health solutions. Menopause, once under-discussed, is now recognized as a critical life stage linked to hormonal changes, bone density loss, cardiovascular risks, metabolic shifts, and mental well-being. This growing awareness is driving demand for digital tools that support symptom tracking, hormone health monitoring, lifestyle guidance, and evidence-based care pathways. FemTech platforms are responding with AI-driven apps, wearable integrations, and telehealth services tailored to menopause management and healthy aging.

In October 2024, Maven Clinic, the world’s largest virtual clinic focused on women’s and family health, announced that it had secured USD 125 million in Series F financing led by StepStone Group. The round also included participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. With this latest raise, Maven Clinic’s total funding has surpassed USD 425 million. This funding highlights strong investor confidence in women’s digital health, accelerating innovation and large-scale adoption of FemTech solutions.

Recent Trends:

AI- and big data-driven personalised healthcare has emerged as a key technological trend in the FemTech market. Instead of relying on generic tracking tools, modern FemTech platforms now process large volumes of diverse data—such as menstrual cycle patterns, hormone indicators, wearable sensor outputs, and lifestyle information—and apply machine-learning algorithms to deliver more precise insights. These models help forecast fertility windows, identify potential risks related to conditions like endometriosis or PCOS, and tailor interventions accordingly.

Within these platforms, embedded algorithms can detect subtle signals, including changes in basal body temperature, heart-rate variability, and sleep patterns, that are associated with ovulation and hormonal transitions. Access to such real-time insights supports preventive, proactive care rather than symptom-driven responses. Women receive timely, actionable recommendations, such as lifestyle adjustments or diagnostic referrals, before issues intensify.

Restraints & Challenges:

Limited clinical validation and insufficient scientific evidence are key factors restraining revenue growth of the market, as they directly affect trust, adoption, and regulatory acceptance. Many solutions rely on self-reported data, proprietary algorithms, or small-scale studies, which makes it difficult for healthcare providers, insurers, and employers to fully endorse or reimburse these technologies. Without robust clinical trials and peer-reviewed evidence, FemTech products often struggle to demonstrate clear efficacy and long-term health outcomes, slowing their integration into formal care pathways. This lack of validation also increases regulatory scrutiny and prolongs approval timelines, raising development costs and delaying commercialization.

Offerings Segment Insights and Analysis:

Based on the offerings, the FemTech market is segmented into products, software and services. Products segment is further sub-segmented into wearables, connected devices, consumables, and others. Software segment is further sub-segmented into mobile apps, Digital Therapeutics (DTx), platforms and others. Services segment is further sub-segmented into telehealth and teleconsultations, wellness programs, payer programs and others.

Products segment contributed the largest share in 2025 due to the rising demand for innovative, technology-enabled solutions that address women’s diverse health needs across different life stages. This segment includes wearables, smart connected devices, and consumable products designed for menstrual, reproductive, maternal, and menopausal care. The surge in global health awareness and the growing acceptance of digital and home-based healthcare have significantly accelerated adoption. Devices such as fertility and ovulation trackers, smart breast pumps, pelvic floor trainers, and connected menstrual health tools are gaining traction due to their convenience, accuracy, and ability to deliver personalized insights.

Recent developments are further accelerating this growth momentum. In March 2025, Willow acquired UK-based Elvie, bringing together complementary capabilities in wearable breast pumps and maternal health technologies to broaden product offerings and strengthen global reach. In a similar vein, Spark Biomedical introduced OhmBody in July 2025, a non-invasive wellness device designed to alleviate menstrual pain and discomfort, highlighting rising innovation in consumer-focused health solutions.  

Technology Segment Insights and Analysis:

Based on technology, the FemTech market is segmented into sensors and biosensors, diagnostics technologies, data and AI, genomics and others.

Sensors and biosensors segment contributed the largest share in 2025 due to rising demand for ultra-dense, durable, and energy-efficient data processing and storage solutions. DNA offers exceptional information density and long-term stability, making it highly attractive for archival data storage, complex computation, and molecular-level data manipulation that conventional silicon technologies struggle to achieve efficiently. Rapid advances in DNA synthesis, sequencing technologies, and error-correction algorithms are improving performance and reducing costs, enabling a shift from experimental research toward early commercial deployment.

Recent industry activity underscores the rapidly building momentum in this segment. In May 2025, Digital Science highlighted a sharp rise in FemTech innovation centered on sensor technologies, with increasing research output and patent filings targeting hormonal and reproductive biomarkers. At the same time, wearable technology providers are rolling out sophisticated multi-sensor platforms capable of monitoring multiple health parameters in parallel, delivering a more holistic picture of women’s physical and hormonal health. Companies such as Ava Women and Bloomlife are at the forefront of this shift, developing fertility and pregnancy wearables that use biosensors to detect subtle physiological signals and translate them into actionable health insights.

Application Segment Insights and Analysis:

Based on application, the FemTech market is segmented into menstrual health, fertility and conception, pregnancy & nursing care, pelvic & uterine health, women’s wellness, menopause care, sexual wellness, oncology screening and others.

Pregnancy and nursing care segment contributed the largest share in 2025 due to the increasing focus on maternal health, rising fertility rates in developing regions, and growing adoption of digital tools for pregnancy monitoring and postpartum care. Expecting and new mothers are increasingly turning to technology-enabled solutions for safe, personalized, and continuous health support during and after pregnancy. FemTech innovations such as smart wearable devices, fetal monitoring systems, tele-obstetric platforms, and lactation management tools are transforming traditional maternal care by offering real-time tracking of vital parameters like fetal heart rate, contractions, blood pressure, and stress levels.

Several recent developments are strengthening momentum in this segment. In May 2025, Willow acquired UK-based Elvie, a pioneer in wearable breast pumps and pelvic floor training solutions, representing a significant consolidation within maternal health technology and broadening the global reach of connected nursing products. At the same time, Bloomlife continues to advance smart prenatal monitoring devices that track uterine activity and help anticipate the onset of labor, supporting earlier intervention and improved safety for both mothers and infants.

Geographical Outlook:

FemTech market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamic. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different region and countries.

North America FemTech Market:

Market in North America accounted for largest revenue share in 2025 due to the advanced digital health infrastructure, high adoption of wellness and fertility apps, and substantial venture capital investments focused on women’s health innovation. The United States remains the frontrunner, supported by the widespread use of fertility tracking applications, at-home hormone diagnostic kits, virtual OB-GYN platforms, and corporate wellness programs tailored for women. Regulatory frameworks such as the FDA’s Digital Health Software Precertification Program have played a vital role in helping FemTech startups accelerate approvals for digital contraceptives, wearable monitoring devices, and menopause management technologies.

Leading companies including Clue, Ava, and Tia have strengthened their direct-to-consumer presence while expanding partnerships with telehealth providers and employer benefit platforms. In April 2022, Conceive, a FemTech startup, raised USD 3.7 million to advance its fertility-focused solutions, reflecting growing investor confidence in women’s health technologies. Such funding activities are expected to drive innovation, enhance product accessibility, and further strengthen FemTech adoption across the U.S. market.

Asia Pacific FemTech Market:

Asia Pacific is expected to register a fast revenue growth rate during the forecast period due to the combination of demographic scale, rising healthcare awareness, and rapid digital adoption across the region. A large female population, coupled with increasing focus on reproductive health, fertility management, maternal care, and menstrual wellness, is expanding the addressable user base. Growing smartphone penetration, affordable internet access, and widespread use of health apps are making digital women’s health solutions more accessible, even beyond major urban centers.

In addition, changing social attitudes and improved health education are reducing taboos around topics such as menstruation, fertility, and menopause. It is encouraging higher adoption of FemTech platforms. In November 2025, China-based FemTech startup Micro Inno, headquartered in Hangzhou, secured eight-figure RMB funding. The investment was co-led by Chuanggu Capital, Hefei Industry Investment, and Guoyuan Equity. The capital will be deployed to develop a dedicated medical device platform for women’s health, while also accelerating product innovation and market commercialization efforts.

Europe FemTech Market:

Market in Europe accounted for a significant revenue share in 2025 due to strong healthcare infrastructure, progressive regulatory frameworks, and rising awareness of women’s health across the region. Increasing focus on reproductive health, fertility management, menopause care, and mental well-being is driving demand for digital and connected health solutions. High smartphone penetration and widespread adoption of digital health platforms are facilitating the integration of FemTech tools into everyday healthcare routines. In addition, supportive government policies and public funding programs are encouraging innovation in women-focused digital health, while healthcare systems are increasingly open to preventive and remote care models that reduce long-term costs.

In July 2025, France-based startup Solence, which offers an app designed to support women living with Polycystic Ovary Syndrome (PCOS), secured Euro 1.6 million (USD 1.9 million) in seed-stage funding. The investment will be used to enhance product capabilities and grow the company’s team. Solence aims to extend healthy life expectancy for women by lowering the impact of chronic conditions through lifestyle-focused interventions and AI-driven therapeutic solutions. This funding highlights growing investor confidence in women-focused digital therapeutics across Europe.

Competition Analysis:

The FemTech market is characterized by a consolidated structure, with few players competing across various segments and regions. List of major players included in the FemTech market report are:

• Flo Health
• Maven Clinic
• Kindbody
• Carrot Fertility
• Chiaro Technology Ltd
• HeraMED
• Elvie
• Hertility Health
• Natural Cycles USA Corp
• Athena Feminine Technologies
• Allara Health
• NUVO Inc
• Aspivix
• MyLivia
• Bloomlife
• Illumigyn

Strategic Developments in FemTech Market:

• In November 2025, Willow, a leading manufacturer of wearable breast pumps, announced the acquisition of UK-based FemTech company Elvie as part of its strategy to expand and integrate their maternal health technology platforms. Since its founding in 2013, Elvie has raised over USD 186 million, reaching a reported valuation of USD 241 million. Willow, which secured USD 55 million in Series C funding in 2020, has accumulated approximately USD 254 million in total funding to date. This acquisition marks a significant step toward strengthening their combined position in the global maternal and women’s health technology market.
• In July 2025, Spark Biomedical and Velentium Medical, long-time collaborators in neuromodulation device development, announced the launch of OhmBody, a new division under Spark Biomedical. The initiative introduces a non-invasive wellness device designed to help alleviate menstrual cramps, reduce excessive menstrual bleeding, and address other period-related symptoms such as fatigue, digestive discomfort, and mood fluctuations. The product aims to promote overall balance and well-being from within, marking a significant advancement in non-invasive solutions for menstrual health management.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2023 to 2024, with 2025 serving as the base year for market size calculations. The forecast period extends from 2026 to 2033.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights of The FemTech Market Report:

 The FemTech market report offers a detailed analysis of market size, including historical revenue (in USD Billion) data for 2023-2024 and revenue forecasts for 2026-2033 across the following segments:

• Offerings Outlook (Revenue, USD Billion; 2023-2033)
  • Products
    • Wearables
    • Connected Devices
    • Consumables
    • Others
  • Software
    • Mobile Apps
    • Digital Therapeutics (DTx)
    • Platforms
    • Others
  • Services
    • Telehealth and Teleconsultations
    • Wellness Programs
    • Payer Programs
    • Others
• Technology Outlook (Revenue, USD Billion; 2023-2033)
  • Sensors and Biosensors
  • Diagnostics Technologies
  • Data and AI
  • Genomics
  • Others
• Application Outlook (Revenue, USD Billion; 2023-2033)
  • Menstrual Health
  • Fertility and Conception
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Health
  • Womens Wellness
  • Menopause Care
  • Sexual Wellness
  • Oncology Screening
  • Others
• End-Use (Revenue, USD Billion; 2023-2033)
  • Direct-to-Consumer (DTC)
  • Hospitals
  • Fertility Clinics
  • Surgical Centers
  • Diagnostic Centers
  • Others
• Distribution Channel (Revenue, USD Billion; 2023-2033)
  • Online Platforms
  • Retail Channels
  • Healthcare Channels
  • Others
• Regional Outlook (Revenue, USD Billion; 2023-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Benelux
    • Nordic Countries
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Oceania
    • ASEAN Countries
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Frequently Asked Questions (FAQ) about the FemTech Market Report